Analysis of association between genetic polymorphisms of the prostaglandin F2 IA receptor gene and response to latanoprost.
前列腺素 F2 IA 受体基因的遗传多态性与拉坦前列素反应之间的关联分析。
基本信息
- 批准号:17591826
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Latanoprost, a prostaglandin F2o analogue, is widely used to lower the intraocular pressure (10P) in patients with glaucoma although in some cases the response is unexpectedly weak. It is currently unknown what is responsible for the weak responses to latanoprost in different patients. We attempted to evaluate the relationship between polymorphisms of the prostaglandin F2n receptor (FP receptor) gene and the effectiveness of topical latanoprost treatment in normal volunteers.Single nucleotide polymorphisms (SNPs) in the FP receptor gene were searched and the genotype was determined mainly by direct DNA sequencing. Ten SNPs were identified in this study. Baseline IOPs of both eyes of 100 normal subjects were measured at three time points. Latanoprost (0.005%) was applied to one eye once daily, for 7 days. Diurnal 10P was measured again on day 7. Response to latanoprost was evaluated by percent 10P reduction in the treated eye minus 10P fluctuations of the non-treated eye. One SNP, rs375 … More 3380, was located in the promoter region of the FP receptor gene and was significantly correlated with the mean diurnal percent 10P reduction (%AIOP) (CC, 20.3 ± 1.5% (mean ± SEM); CT + TT, 15.6 ± 1.2%, P = 0.0316). The %AIOP was not correlated with other SNPs. We classified subjects by the %ΔI0P into 3 groups: low-responders (%ΔIOP <10%), medium-responders (10%<%ΔIOP <25%), and high-responders (%Δ10P<25%). When the category classified by the %oIOP was analyzed, not only rs3753380 but also rs3766355, a SNP in intron 1, were associated with the degree of response to latanoprost. A promoter assay with a reporter luciferase gene revealed that the C allele of rs3766355 and T allele of rs3753380 were found in constructs with lower transcriptional activity of the FP receptor gene.rs3753380 and rs3766355, SNPs in the promoter and intron 1 regions of the FP receptor gene, correlate with a response to short-term latanoprost treatment in normal volunteers. The genotype of these SNPs may be an important determinant of variability in response to latanoprost. Less
拉坦前列素是一种前列腺素f2O类似物,广泛用于降低青光眼患者的眼压(10P),尽管在某些情况下反应出乎意料地弱。目前尚不清楚是什么原因导致不同患者对拉坦前列素的弱反应。为探讨前列腺素F2n受体(FP受体)基因多态性与拉坦前列素治疗效果的关系,对FP受体基因进行单核苷酸多态性(SNPs)分析,并通过DNA直接测序确定基因分型。在本研究中发现了10个SNP。在3个时间点测量100例正常人双眼的基线眼压。拉坦前列素(0.005%)用于单眼,每日1次,连用7天。在第7天再次测量昼夜10P。通过治疗眼10P减少百分比减去非治疗眼10P波动来评估对拉坦前列素的反应。一个SNP,rs375…My 3380位于FP受体基因启动子区域,与日均10p下降百分率显著相关(CC,20.3±1.5%;CT+TT,15.6±1.2%,P=0.0316)。AIOP与其他SNPs无相关性。我们根据%ΔIOP将受试者分为三组:低响应者(%ΔIOP;10%)、中等响应者(10%ΔIOP<;25%)和高响应者(%Δ10p<;25%)。当分析按%oIOP分类的类别时,不仅rs3753380,而且rs3766355,内含子1中的SNP,都与拉坦前列素的疗效相关。报告荧光素酶基因的启动子分析显示,rs3766355的C等位基因和rs3753380的T等位基因存在于FP受体基因转录活性较低的结构中。在正常志愿者中,FP受体基因启动子和内含子1区域的rs3753380和rs3766355 SNPs与短期拉坦前列素治疗的疗效相关。这些SNPs的基因型别可能是拉坦前列素疗效变异的重要决定因素。较少
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Association between Genetic Polymorphisms of the Prostaglandin F2α Receptor Gene and Response to Latanoprost
- DOI:10.1016/s0084-392x(08)79152-4
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:L. Katz
- 通讯作者:L. Katz
Association between Genetic Polymorphisms of the Prostaglandin F2□ Receptor Gene and Response to Latanoprost.
前列腺素F2□受体基因的遗传多态性与拉坦前列素反应之间的关联。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:Sakurai M;Higashide T;Takahashi M;Sugiyama K
- 通讯作者:Sugiyama K
In vivo imaging and quantitative evaluation of the rat retinal nerve fiber layer using scanning laser ophthalmology.
使用扫描激光眼科对大鼠视网膜神经纤维层进行体内成像和定量评估。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Ichiro Kawaguchi;Tomomi Higashide;Shinji Ohkubo;Hisashi Takeda;Kazuhisa Sugiyama
- 通讯作者:Kazuhisa Sugiyama
Circadian intraocular pressure rhythm is generated by clock genes
- DOI:10.1167/iovs.06-0183
- 发表时间:2006-09-01
- 期刊:
- 影响因子:4.4
- 作者:Maeda, Ari;Tsujiya, Sosuke;Sugiyama, Kazuhisa
- 通讯作者:Sugiyama, Kazuhisa
Association between genetic polymorphisms of the prostaglandin F2n Receptor gene and response to Latanoprost.
前列腺素 F2n 受体基因的遗传多态性与拉坦前列素反应之间的关联。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:Mayumi Sakurai;Tomomi Higashide;Mami Takahashi;Kazuhisa Sugiyama.
- 通讯作者:Kazuhisa Sugiyama.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAKURAI Mayumi其他文献
SAKURAI Mayumi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAKURAI Mayumi', 18)}}的其他基金
Role of sympathetic nervous system in diurnal fluctuation of intraocular pressure
交感神经系统在眼压昼夜波动中的作用
- 批准号:
22591935 - 财政年份:2010
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Association between response to antiglaucomatous drug and genetic polymorphisms of the target protein.
对抗青光眼药物的反应与目标蛋白的遗传多态性之间的关联。
- 批准号:
19592008 - 财政年份:2007
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
PERSONALIZED DRUG RESPONSE: IMPLEMENTATION and EVALUATION in CKD
个性化药物反应:CKD 中的实施和评估
- 批准号:
10076730 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
EU-Funded
Multi-modal insights of spatially distributed cells with associations of diseases and drug response
空间分布细胞与疾病和药物反应关联的多模式见解
- 批准号:
10714602 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Characterizing diacetylspermine as a biomarker of drug response and precision treatment in triple-negative breast cancer
将二乙酰精胺作为三阴性乳腺癌药物反应和精准治疗的生物标志物
- 批准号:
494927 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Operating Grants
Cancer Patients Digital Twins to Investigating disease fragmentation and its impact on drug response in AML trials
癌症患者数字孪生研究 AML 试验中的疾病碎片化及其对药物反应的影响
- 批准号:
2881649 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Studentship
PERSONALIZED DRUG RESPONSE: IMPLEMENTATION and EVALUATION in CKD
个性化药物反应:CKD 中的实施和评估
- 批准号:
10064411 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
EU-Funded
Role of the RAS Pathway Activation on the Biology and Drug Response of Acute Myeloid Leukemias
RAS 通路激活对急性髓系白血病生物学和药物反应的作用
- 批准号:
468616 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
Operating Grants
Characterizing and validating diacetylspermine as a metabolic biomarker of drug response and precision treatment in triple-negative breast cancer
表征和验证二乙酰精胺作为三阴性乳腺癌药物反应和精准治疗的代谢生物标志物
- 批准号:
472346 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
Operating Grants
Developing Improved Models of Basal Cell Carcinoma to Evaluate Tumor-Drug Response
开发改进的基底细胞癌模型以评估肿瘤药物反应
- 批准号:
10518702 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
Interpretable deep learning models for the prediction of cancer drug response
用于预测癌症药物反应的可解释深度学习模型
- 批准号:
547673-2020 - 财政年份:2022
- 资助金额:
$ 2.18万 - 项目类别:
Postgraduate Scholarships - Doctoral
Predicting drug response for basal cell carcinoma by comprehensive genomic analysis.
通过综合基因组分析预测基底细胞癌的药物反应。
- 批准号:
21K16898 - 财政年份:2021
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists